New cargo results released delivering Cre enzyme, page-31

Hi Tony
I was under the impression peptidream produce both therapeutic peptides and peptide drug conjugates. They specifically seem to seperate out any peptide drug conjugates from many of their current deals to be a seperate licensed product i think. Would they need a fpp peptide to use in conjunction with their therapeutic peptide?? I would have thought the point of their scans and the interest generated is they already show effect on cells as required for therapeutic peptides?? I was thinking the main interest for peptidream in pyc fpp might be if they havent yet mastered enddosomal escape with peptide drug conjugates?? It seems the fact they always seem to seperate drug conjugates from current deals indicates they see a value, and maybe endosomal escape is their stumbling block, hence why they target therapeutics mainly??